Equifax Q1 2026 earnings in focus
Equifax (EFX) opened 2026 with Q1 revenue of US$1.6 billion and basic EPS of US$1.43, backed by trailing twelve month EPS of US$5.72 and net income of US$698.7 million as investors weigh what these results say about earnings momentum. The company has seen revenue move from US$1,442 million and EPS of US$1.07 in Q1 2025 to US$1,648.9 million and EPS of US$1.43 in Q1 2026, while trailing twelve month revenue and EPS have shifted from US$5.7 billion and US$4.94 a year ago to US$6.3 billion and US$5.72. With net margin ticking up to 11.1% over the last year, the story this quarter is about how sustained profitability interacts with expectations for future growth.
See our full analysis for Equifax.
The next step is to set these earnings against the main narratives around Equifax to see which views the latest numbers support and which they call into question.
See what the community is saying about Equifax
NYSE:EFX Revenue & Expenses Breakdown as at Apr 2026
Margins supported by 11.1% net level
- Over the last 12 months, Equifax earned US$698.7 million on US$6.3b of revenue, giving an 11.1% net margin compared with 10.7% a year earlier.
- Consensus narrative argues that cloud migration and new platforms can help margins, and the current 11.1% net margin offers a reference point for that view.
- With trailing EPS at US$5.72 and trailing revenue at US$6.3b, the margin profile aligns with the idea that technology investments and broader data products are supporting profitability.
- At the same time, ongoing litigation and compliance costs mentioned in the cautious narrative sit against this margin level, so any rise in those costs would show up quickly in this percentage.
14.1% earnings growth under the microscope
- Trailing 12 month earnings grew 14.1% year over year, alongside Q1 2026 net income of US$171.5 million versus US$133.1 million in Q1 2025.
- Bulls point to new product solutions and a growing data moat as key drivers, and this 14.1% earnings growth rate is often used to back that up.
- The Work Number record base and higher NPI activity mentioned in the bullish case are consistent with trailing EPS rising from US$4.94 to US$5.72, which supports the idea of stronger monetization of data.
- However, the same narrative flags higher litigation expenses and government budget pressure, so investors watching this 14.1% figure may look to see if it holds up as those costs and contract delays play through future results.
On top of that growth profile, some investors look at how the bullish and cautious views stack up against the actual numbers before deciding which side they find more convincing. 🐂 Equifax Bull Case
Premium 33.2x P/E and upside debate
- The stock trades on a trailing P/E of 33.2x versus 19.8x for the US Professional Services industry and 32.3x for peers, while the current share price of US$192.42 sits below an analyst price target of US$232.57 and a DCF fair value of about US$384.33.
- Bears focus on this premium multiple and Equifax’s higher debt level, and those concerns sit directly against valuation signals that point to upside.
- On one hand, analyst targets imply around 20.9% upside from US$192.42 to US$232.57, and the DCF fair value of roughly US$384.33 is much higher again, which both support a constructive view on long term earnings power.
- On the other hand, a trailing P/E of 33.2x above the 19.8x industry level means any disappointment versus the forecast 17.9% annual earnings growth or 8.6% revenue growth could weigh heavily on that valuation, especially with a high debt load already flagged as a risk.
Skeptics who focus on the 33.2x P/E and debt concerns often want to see how a cautious thesis handles these upside signals from targets and DCF work. 🐻 Equifax Bear Case
Next Steps
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Equifax on Simply Wall St. Add the company to your watchlist or portfolio so you’ll be alerted when the story evolves.
With both optimism and caution running through these numbers, it makes sense to move fast and test the story against your own expectations by weighing 4 key rewards and 1 important warning sign.
See What Else Is Out There
Equifax’s rich 33.2x P/E, high debt concerns, and reliance on forecast growth leave little room for error if the story weakens.
If that premium valuation and leverage make you hesitant, it could be worth shifting some research time toward companies in the solid balance sheet and fundamentals stocks screener (41 results) that pair earnings power with stronger financial footing.
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we’re here to simplify it.
Discover if Equifax might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free Analysis
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]
